Breast Neoplasms: all 12,820 studies

Page 40 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to AnthracyclinesCompletedNCT01754597Not applicableResults posted
• Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryTerminatedNCT01754519Phase 2Results posted
• Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and PegfilgrastimCompletedNCT01752907Phase 2Results posted
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerCompletedNCT01750073Phase 2Results posted
• Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast CancerTerminatedNCT01745367Phase 2Results posted
• An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker AnalysisCompletedNCT01743560Phase 4Results posted
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)CompletedNCT01740427Phase 3Results posted
• Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing RadiotherapyCompletedNCT01740323Phase 2Results posted
• Cabozantinib for Metastatic Triple Negative BrCaCompletedNCT01738438Phase 2Results posted
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®CompletedNCT01735175Phase 3Results posted
• Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal CancerCompletedNCT01733628Results posted
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCompletedNCT01730833Phase 2Results posted
• Cabergoline in Metastatic Breast CancerCompletedNCT01730729Early Phase 1Results posted
• Ad/HER2/Neu Dendritic Cell Cancer Vaccine TestingCompletedNCT01730118Phase 1Results posted
• Single Fraction Elderly Breast Irradiation (SiFEBI)CompletedNCT01727011Not applicableResults posted
• An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast CancerCompletedNCT01725386Results posted
• PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerActive, not recruitingNCT01723774Phase 2Results posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone TherapyCompletedNCT01720602Not applicableResults posted
• MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity AddendumCompletedNCT01719562Not applicableResults posted
• NOLAN: Naproxen or Loratadine and NeulastaCompletedNCT01712009Phase 2Results posted
• Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast CancerCompletedNCT01705691Phase 2Results posted
• Breast Cup Immobilization Device II (GCC 1047)CompletedNCT01704547Results posted
• Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.TerminatedNCT01703754Phase 2Results posted
• A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentCompletedNCT01702571Phase 3Results posted
• A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)TerminatedNCT01702558Phase 2Results posted
• Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)CompletedNCT01699867Results posted
• Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerCompletedNCT01698918Phase 2Results posted
• Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone TherapyCompletedNCT01697345Early Phase 1Results posted
• Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerCompletedNCT01688609Phase 2Results posted
• A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerCompletedNCT01684215Phase 2Results posted
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingNCT01674140Phase 3Results posted
• A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast CancerCompletedNCT01674062Phase 2Results posted
• Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
• Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast CancerCompletedNCT01670877Phase 2Results posted
• Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCaCompletedNCT01670500Phase 2Results posted
• Aromatase Inhibitor Host Factors StudyCompletedNCT01669343Not applicableResults posted
• Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional MammographyCompletedNCT01669148Not applicableResults posted
• An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast CancerCompletedNCT01664494Results posted
• Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast CancerCompletedNCT01663727Phase 3Results posted
• Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.CompletedNCT01649271Phase 1Results posted
• Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyCompletedNCT01648322Phase 2Results posted
• 4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast CancerCompletedNCT01646346Not applicableResults posted
• Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant TherapyCompletedNCT01645059Results posted
• A Phase III Study of NK105 in Patients With Breast CancerCompletedNCT01644890Phase 3Results posted
• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORiTerminatedNCT01633060Phase 3Results posted
• Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerCompletedNCT01631552Phase 1/2Results posted
• A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast CancerCompletedNCT01629615Phase 2Results posted
• Exemestane-RAD001-MetforminTerminatedNCT01627067Phase 2Results posted
• Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer PatientsCompletedNCT01625286Phase 1/2Results posted
• A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyCompletedNCT01624220Not applicableResults posted
• Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerCompletedNCT01622868Phase 2Results posted
• 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the BrainCompletedNCT01621906Not applicableResults posted
• A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast CancerCompletedNCT01617668Phase 2Results posted
• Phase II Study of GTx024 in Women With Metastatic Breast CancerTerminatedNCT01616758Phase 2Results posted
• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorCompletedNCT01610284Phase 3Results posted
• A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)CompletedNCT01605396Phase 2Results posted
• S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyCompletedNCT01598298Phase 3Results posted
• Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast CancerCompletedNCT01597193Phase 1Results posted
• Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast CancerCompletedNCT01596751Phase 1/2Results posted
• Ruxolitinib in Estrogen Receptor Positive Breast CancerCompletedNCT01594216Phase 2Results posted
• Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2CompletedNCT01593020Phase 2Results posted
• Home-Based Symptom Management Via Reflexology for Breast Cancer PatientsCompletedNCT01582971Not applicableResults posted
• External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 WeeksCompletedNCT01581619Not applicableResults posted
• Tivantinib in Treating Patients With Recurrent or Metastatic Breast CancerCompletedNCT01575522Phase 2Results posted
• Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentCompletedNCT01573442Phase 3Results posted
• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K ActivationCompletedNCT01572727Phase 2/3Results posted
• A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerCompletedNCT01572038Phase 3Results posted
• Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVaxCompletedNCT01570036Phase 2Results posted
• A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerCompletedNCT01566721Phase 3Results posted
• Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerCompletedNCT01565499Phase 2Results posted
• A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerCompletedNCT01565083Phase 2Results posted
• DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant ChemotherapyCompletedNCT01564368Not applicableResults posted
• Ruxolitinib in Patients With Breast CancerTerminatedNCT01562873Phase 2Results posted
• Fulvestrant With or Without Ganetespib in HR+ Breast CancerCompletedNCT01560416Phase 2Results posted
• Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast CancerCompletedNCT01556243Phase 2Results posted
• Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor MalignanciesCompletedNCT01554371Phase 1/2Results posted
• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerCompletedNCT01547741Phase 3Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast CancerCompletedNCT01546649Phase 3Results posted
• Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast CancerTerminatedNCT01545648Phase 2Results posted
• Therapy to Prevent Sexual Pain in Breast Cancer SurvivorsCompletedNCT01539317Phase 3Results posted
• Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and CyclophosphamideCompletedNCT01537029Phase 4Results posted
• Memantine Hydrochloride in Helping Cancer Survivors Stop SmokingCompletedNCT01535040Phase 2Results posted
• Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast CancerTerminatedNCT01528345Phase 2Results posted
• Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast CancerCompletedNCT01527487Phase 2Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerActive, not recruitingNCT01525966Phase 2Results posted
• A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast CancerCompletedNCT01525589Phase 2Results posted
• Phase III Study Comparing the Efficacy and Safety of EP2006 and FilgrastimCompletedNCT01519700Phase 3Results posted
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimCompletedNCT01516736Phase 3Results posted
• Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)CompletedNCT01509625Results posted
• Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerCompletedNCT01506609Phase 2Results posted
• Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast CancerTerminatedNCT01499160Phase 2Results posted
• Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerTerminatedNCT01498588Phase 2Results posted
• Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast CancerCompletedNCT01498458Phase 1Results posted
• HKI-272 for HER2-Positive Breast Cancer and Brain MetastasesCompletedNCT01494662Phase 2Results posted
• The BEACON Study (Breast Cancer Outcomes With NKTR-102)CompletedNCT01492101Phase 3Results posted
• A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerCompletedNCT01491737Phase 2Results posted
• Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation TherapyCompletedNCT01487954Phase 2Results posted
• Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast CancerTerminatedNCT01484041Phase 1/2Results posted
• An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 YearsCompletedNCT01480674Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted

← Breast Neoplasms overview